Stephanie Okey

Companies

• Crinetics PharmaceuticalsBoard member Jul 16, 2019 to now¹
• PTC TherapeuticsBoard member Dec 18, 2018 to now²
• Catalent Pharma SolutionsBoard member Aug 30, 2023 to Dec 18, 2024³
• ALBIREO PHARMA, INC.Board member Jun 11, 2018 to Mar 2, 2023⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• PTC Therapeutics PTCT8,000 shares⁵$491.0K at $61.38Mar 10, 2026
• Catalent Pharma Solutions CTLT0 shares⁶Dec 18, 2024
• Crinetics Pharmaceuticals0 shares⁷Sep 1, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 1, 2026Returned to company 5,925 shares at $85.00 of Crinetics Pharmaceuticals⁷
• Sep 1, 2026Returned to company 6,400 shares at $85.00 of Crinetics Pharmaceuticals⁷
• Jun 18, 2026Granted 5,925 shares of Crinetics Pharmaceuticals⁸
• Jun 17, 2026Sold 608 shares at $36.22 of Crinetics Pharmaceuticals⁹
• Jun 17, 2026Sold 6,292 shares at $35.62 of Crinetics Pharmaceuticals⁹
• Mar 10, 2026Sold 14,000 shares at $70.00 of PTC Therapeutics⁵
• Mar 10, 2026Exercised options 14,000 shares at $33.63 of PTC Therapeutics⁵
• Mar 10, 2026Sold 1,167 shares at $70.00 of PTC Therapeutics⁵
• Mar 10, 2026Exercised options 1,167 shares at $33.63 of PTC Therapeutics⁵
• Mar 5, 2026Sold 6,333 shares at $63.38 of PTC Therapeutics¹⁰
• Mar 3, 2026Sold 3,000 shares at $39.67 of Crinetics Pharmaceuticals¹¹
• Jan 2, 2026Granted 4,000 shares of PTC Therapeutics¹²
• Nov 20, 2025Gift 867 shares of PTC Therapeutics¹³
• Jun 11, 2025Granted 6,900 shares of Crinetics Pharmaceuticals¹⁴
• Mar 13, 2025Sold 5,000 shares at $54.00 of PTC Therapeutics¹⁵
• Jan 3, 2025Granted 4,000 shares of PTC Therapeutics¹⁶
• Dec 18, 2024Returned to company 12,635 shares of Catalent Pharma Solutions⁶
• Oct 30, 2024Granted 4,663 shares of Catalent Pharma Solutions¹⁷
• Jun 7, 2024Granted 3,400 shares of Crinetics Pharmaceuticals¹⁸
• Mar 28, 2024Sold 17,500 shares at $46.38 of Crinetics Pharmaceuticals¹⁹
• Mar 28, 2024Exercised options 17,500 shares at $18.29 of Crinetics Pharmaceuticals¹⁹
• Feb 15, 2024Granted 4,000 shares of PTC Therapeutics²⁰
• Oct 27, 2023Granted 6,993 shares of Catalent Pharma Solutions²¹
• Aug 28, 2023Granted 979 shares of Catalent Pharma Solutions²²
• Jun 16, 2023Granted 6,000 shares of Crinetics Pharmaceuticals²³